- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04224883
Effect of Different Feeding Method on Gastrointestinal Function of Critical Patients (DFM-GFC)
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Guang Yang
- Phone Number: 86-20-39318526
- Email: yangguang@gzucm.edu.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Recruiting
- 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Contact:
- Guang Yang
- Phone Number: 86-20-39318526
- Email: yg_1918@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Septic patients in Department of Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine;
- APACHE-Ⅱ score greater than 15 points;
- Signing the informed consent.
Exclusion Criteria:
- Fasting patients in the clinical, such as digestive tract perforation, bleeding or postoperative patients with gastrointestinal tract;
- Allergic to enteral nutrition preparations;
- Don't want to attend the test or not with the healer.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 24-hours group
The critical patients randomized to 24-hours group will be received enteral nutrition preparation by 24 hours of continuously pumping through stomach tube every day. Feeding will be started within 24 hours in admission of ICU. The time of therapy is 5 days. |
Daily amount of feeding were continuously pumped for 24 hours.
EN preparation pumping scheme was as follows: The initial pumping speed was average pumping volume of total enteral nutrition in one day, and gastric residual volumes is checked every 4 hours.
If it is not tolerable, the speed of the pumping is reduced by half on the original speed.
GRV<200mL were considered markers of good tolerance.Feeding intolerance was defined as GRV>200 mL.
If GRV>500mL, EN was stopped and reassessed after 4 hours.
Other Names:
|
Experimental: 16-hours group
The critical patients randomized to 16-hours group will be received enteral nutrition preparation by 16 hours of continuously pumping through stomach tube every day. Feeding will be started within 24 hours in admission of ICU. The time of therapy is 5 days. |
Daily amount of feeding were continuously pumped for 16 hours.EN preparation pumping scheme was as follows: The initial pumping speed was average pumping volume of total enteral nutrition in one day, and gastric residual volumes is checked every 4 hours.If it is not tolerable, the speed of the pumping is reduced by half on the original speed.
GRV<200 mL were considered markers of good tolerance.
Feeding intolerance was defined as GRV>200 mL.
If GRV>500mL, EN was stopped and reassessed after 4 hours.
Other Names:
|
Experimental: intermittent group
The critical patients randomized to intermittent group will be received enteral nutrition preparations by four meals every day(08:00,12:00 18:00,22:00), each meal are pumped within 60min or 120min through stomach tube.Feeding will be started within 24 hours in admission of ICU.
The time of therapy is 5 days
|
Daily amount of feeding were divided into four meals, each meal are pumped within 60mins or 120mins through stomach tube.
EN preparation pumping scheme was as follows: If the volume of each meal is less than or equal to 250ml(≤250ml), pump in within 60min, if volume is greater than 250ml(>250ml), pump in within 120min and gastric residual volumes is checked before each intermittent feeding.
If it can be tolerated, the velocity of the pumping can be increased by half of the original speed.If it is not tolerable, the speed of the pumping is reduced by half on the original speed.
GRV<200 mL were considered markers of good tolerance.
Feeding intolerance was defined as GRV>200 mL.
If GRV>500mL, EN was stopped and reassessed after 4 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The mean time(hours) that reach to the caloric goal in every group
Time Frame: First 5 days after intervention
|
Caloric goals using 25 kcal/kg (ideal body weight) for caloric need calculated by a single nutritionist.
|
First 5 days after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The rate of onset of Gastric residual (%)
Time Frame: First 5 days after intervention
|
The definition of gastric residual is that gastric residual volume more than 500 ml.
Comparison of rate of gastric residual among three groups.
|
First 5 days after intervention
|
Abdominal pressure (mmHg)
Time Frame: baseline and 5th day
|
Abdominal pressure measurement: through the bladder indirect pressure measurement method, first taking the supine position, emptying the bladder urine, secondly pouring 50ml saline into the balloon catheter, to the pubic symphysis as the base point, keeping the piezometric tube be perpendicular to the ground, then abdominal pressure can be obtained indirectly.
|
baseline and 5th day
|
the rate of new onset pneumonia (%)
Time Frame: First 5 days after intervention
|
Diagnosis of onset pneumonia is defined as two of the following clinical criteria were required.
Fever (>38.3℃) or hypothermia (≤36.0℃),
leukocytosis (>10×10E9 cells/liter) or leukopenia (≤4×10E9 cells/liter), purulent tracheal aspirate or sputum.
The rate of onset pneumonia be counted in each group.
|
First 5 days after intervention
|
The rate(%) of people whom can reaching the caloric goal
Time Frame: First 5 days after intervention
|
Caloric goals using 25 kcal/kg (ideal body weight) for caloric need calculated by a single nutritionist.
|
First 5 days after intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
length of ICU stay (in days)
Time Frame: up to 12 weeks
|
length of ICU stay (in days)
|
up to 12 weeks
|
ICU mortality rate (%)
Time Frame: 28 days after intervention
|
ICU mortality rate (%)
|
28 days after intervention
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012 Mar;40(3):754-61. doi: 10.1097/CCM.0b013e318232db65. Erratum In: Crit Care Med. 2012 Oct;40(10):2932.
- Nieuwenhuijzen GA, Deitch EA, Goris RJ. The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome. J Anat. 1996 Dec;189 ( Pt 3)(Pt 3):537-48.
- Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol. 1996 Sep;91(9):1697-710.
- Yang G, Deng A, Zheng B, Li J, Yu Y, Ouyang H, Huang X, Chen H. Effect of different feeding methods on gastrointestinal function in critical patients (DFM-GFC): study protocol for a randomized controlled trial. Trials. 2022 Oct 20;23(1):882. doi: 10.1186/s13063-022-06807-7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DFM-GFC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on Continuously feeding
-
Guangdong Provincial Hospital of Traditional Chinese...WithdrawnSepsis | Intestinal DysfunctionChina
-
Bispebjerg HospitalRigshospitalet, Denmark; Emergency Medical Services, Capital Region, Denmark; Technical University of DenmarkRecruitingVital Sign Monitoring | Clinical Deterioration | Hospital At HomeDenmark
-
Rigshospitalet, DenmarkUniversity Hospital Bispebjerg and Frederiksberg; Technical University of DenmarkCompletedClinical Deterioration | Vital SignDenmark
-
Bispebjerg HospitalRigshospitalet, Denmark; Technical University of DenmarkCompletedDisease Progression | Disease Attributes | Vital Sign Monitoring | Clinical DeteriorationDenmark
-
Rigshospitalet, DenmarkUnknown
-
NestléCompleted
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Taichung Veterans General HospitalUnknown